Product Images Duloxetine
View Photos of Packaging, Labels & Appearance
Product Label Images
The following 12 images provide visual information about the product associated with Duloxetine NDC 50090-6775 by A-s Medication Solutions, such as packaging, labeling, and the appearance of the drug itself. This resource could be helpful for medical professionals, pharmacists, and patients seeking to verify medication information and ensure they have the correct product.
Structure - beae9b9a d630 463b ae93 f3da73c7049e 01
Figure 1 - beae9b9a d630 463b ae93 f3da73c7049e 02
This text provides data on the proportion of patients with relapse in a treatment study. The treatment options mentioned are "Placebo" and "DULOXETINE". The numbers 08, 04, 02, and 00 may represent the percentage of patients with relapse for each treatment group. The chart shows a time axis ranging from 0 to 150 days, indicating the time from randomization to relapse. The method used to estimate the relapse rate is the Kaplan-Meier estimator. The texts also mention numbers 50, 100, 150, and 20, but their meaning is unclear without additional context.*
Figure 2 - beae9b9a d630 463b ae93 f3da73c7049e 03
The text provided is a table showing the proportion of patients with relapse for a specific treatment (Placebo - DULOXETINE) at different time intervals (in days) from randomization. The table includes values for the proportion of relapsed patients for each time interval.*
Figure 1 - beae9b9a d630 463b ae93 f3da73c7049e 04
Figure 2 - beae9b9a d630 463b ae93 f3da73c7049e 05
fig 5 - beae9b9a d630 463b ae93 f3da73c7049e 06
fig 6 - beae9b9a d630 463b ae93 f3da73c7049e 07
Fig 7 - beae9b9a d630 463b ae93 f3da73c7049e 08
Figure 7 shows the percentage of pediatric patients aged 13 to 17 years old with Juvenile Fibromyalgia Syndrome achieving various levels of pain relief after 12 weeks of treatment. The study (FM-4) evaluated the efficacy of Duloxetine 60mg once daily compared to a placebo. The graph displays the percentage of patients who experienced improvement in pain levels, ranging from 0 to 100 percent. The pain relief was measured using the Brief Pain Inventory - Modified short Form: Adolescent Version Average Pain Score. Patients in the Duloxetine group received 30 mg once daily for the first week and then were titrated to 60 mg once daily for the remaining 12 weeks, based on tolerability.*
Figure 8 - beae9b9a d630 463b ae93 f3da73c7049e 09
Figure 9 - beae9b9a d630 463b ae93 f3da73c7049e 10
Percentage of Patients Improved: This text provides information on the percentage of patients who experienced improvement in their condition. Unfortunately, there are some characters missing or unreadable, making it difficult to determine the full context of the information.*
Figure 10 - beae9b9a d630 463b ae93 f3da73c7049e 11
Percentage of Patients Improved: This text provides information about the percentage of patients who experienced improvement in a specific condition. However, the rest of the information is not readable and cannot be used to generate a useful description.*
Label Image - lbl500906775
This is a product description for a medication called "BOLoXETINE Delayed-Release 60 mg". It is a capsule that comes in a pack of 30. The text also mentions the storage temperature of 77 degrees Celsius.*
* The product label images have been analyzed using a combination of traditional computing and machine learning techniques. It should be noted that the descriptions provided may not be entirely accurate as they are experimental in nature. Use the information in this page at your own discretion and risk.